Study to Explore Drug-drug Interactions Between DWC20155 and DWC20156 in Healthy Subjects

Daewoong Pharmaceutical Co. LTD.40 enrolled

Overview

A randomized, open-label, oral dose, crossover study to explore drug-drug interactions between DWC20155 and DWC20156 in healthy subjects.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Sex: ALLMin age: 19 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Accepts healthy volunteers. Exclusion Criteria: * Who has allergy to investigational product

Busan Paik Hospital

Busan, South Korea

Peak Plasma Concentration (Cmax)

Time frame: 0~24hr

Area under the plasma concentration versus time curve (AUC)

Time frame: 0~24h

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.